These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6021568)

  • 1. Drug costs and drug safety.
    Can Med Assoc J; 1967 Apr; 96(16):1166-7. PubMed ID: 6021568
    [No Abstract]   [Full Text] [Related]  

  • 2. [Organization of a unit for phase I studies].
    Jaillon P; Thiercelin JF; Demarez JP
    J Pharmacol; 1986; 17 Suppl 1():4-11. PubMed ID: 3747539
    [No Abstract]   [Full Text] [Related]  

  • 3. [The cost of drugs].
    Hamel G
    Laval Med; 1968 Jun; 39(6):488-94. PubMed ID: 5679194
    [No Abstract]   [Full Text] [Related]  

  • 4. How Canada holds down drug costs.
    Douglas V
    Forum (Wash); 1977; 1(2):2-5. PubMed ID: 565320
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug protection for Canadians.
    Ordway EM
    Can Nurse; 1967 May; 63(5):38-41. PubMed ID: 6023339
    [No Abstract]   [Full Text] [Related]  

  • 6. How cheap are Canada's drugs really?
    Hollis A
    J Pharm Pharm Sci; 2004 Jun; 7(2):215-6. PubMed ID: 15367378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomics of adverse drug reactions.
    Lundkvist J; Jönsson B
    Fundam Clin Pharmacol; 2004 Jun; 18(3):275-80. PubMed ID: 15147278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spending on drugs surpasses $10 billion.
    Buske L
    CMAJ; 1998 Feb; 158(3):456. PubMed ID: 9484270
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmaceutical industry -- will Canada become a major research centre?
    Gray C
    Can Med Assoc J; 1981 Apr; 124(7):910, 914-5, 918 concl. PubMed ID: 7214290
    [No Abstract]   [Full Text] [Related]  

  • 10. Are generics a drug on the market?
    Tyler VE
    J Indiana State Med Assoc; 1980 Jul; 73(7):452-7. PubMed ID: 7452036
    [No Abstract]   [Full Text] [Related]  

  • 11. The pacemaker challenge.
    Goldman BS; Noble EJ; Heller JG; Covvey D
    Can Med Assoc J; 1974 Jan; 110(1):28-31. PubMed ID: 4809444
    [No Abstract]   [Full Text] [Related]  

  • 12. The physician's pathway for lower drug costs.
    Goldberg HC
    J Fla Med Assoc; 1977 Mar; 64(3):173-5. PubMed ID: 845588
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription drugs: the facts about Canada.
    Consum Rep; 2005 Oct; 70(10):50-1. PubMed ID: 16163821
    [No Abstract]   [Full Text] [Related]  

  • 14. [The drug problem in the opinion of working women--representative study].
    Biener K
    Offentl Gesundheitswes; 1981 Nov; 43(11):578-82. PubMed ID: 6212804
    [No Abstract]   [Full Text] [Related]  

  • 15. The MAC program and wholesale drug prices, a preliminary analysis.
    Dickens PF; Hogan TD
    Res Stat Note; 1977 Jul; (11):1-4. PubMed ID: 10316558
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug cost review--1987.
    Mehl B
    Hosp Pharm; 1988 Mar; 23(3):282-3. PubMed ID: 10318046
    [No Abstract]   [Full Text] [Related]  

  • 17. [The physician and drug costs].
    Kimbel KH
    MMW Munch Med Wochenschr; 1977 Aug; 119(34):1061-2. PubMed ID: 408652
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 19. The drug-device interface.
    Cutler IR
    Med Device Technol; 1993 Jun; 4(5):48-51. PubMed ID: 10171678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Legal aspects of medication prescription].
    Ludwig WD
    Z Arztl Fortbild Qualitatssich; 2005 Apr; 99(2):156-60; discussion 166, 168. PubMed ID: 15957663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.